The global cell line development market is anticipated to reach US$ 7.2 billion by 2028, rising at a CAGR of 7.5% over the forecast period (2022-2028), from an estimated US$ 4.7 billion in 2022. Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient …
Continue reading “Cell Line Development Market Size to Hit USD 7.2 Billion in 2028”